[1]
M. Setina, E. Setina, Z. Doljak, K. Goricar, V. Dolzan, and V. Kovac, “Genetic variability of HIF1A and response to treatment with cisplatin in combination with pemetrexed or gemcitabine in patients with malignant mesothelioma”, Radiol Oncol, vol. 59, no. 3, pp. 403–411, Sep. 2025.